93 related articles for article (PubMed ID: 29099287)
1. PAX5 gene as a novel methylation marker that predicts both clinical outcome and cisplatin sensitivity in esophageal squamous cell carcinoma.
Kurimoto K; Hayashi M; Guerrero-Preston R; Koike M; Kanda M; Hirabayashi S; Tanabe H; Takano N; Iwata N; Niwa Y; Takami H; Kobayashi D; Tanaka C; Yamada S; Nakayama G; Sugimoto H; Fujii T; Fujiwara M; Kodera Y
Epigenetics; 2017; 12(10):865-874. PubMed ID: 29099287
[TBL] [Abstract][Full Text] [Related]
2. Genomic and epigenomic evolution of acquired resistance to combination therapy in esophageal squamous cell carcinoma.
Min Q; Wang Y; Wu Q; Li X; Teng H; Fan J; Cao Y; Fan P; Zhan Q
JCI Insight; 2021 Sep; 6(17):. PubMed ID: 34494553
[TBL] [Abstract][Full Text] [Related]
3. Targeting epigenetic deregulations for the management of esophageal carcinoma: recent advances and emerging approaches.
Ahuja P; Yadav R; Goyal S; Yadav C; Ranga S; Kadian L
Cell Biol Toxicol; 2023 Dec; 39(6):2437-2465. PubMed ID: 37338772
[TBL] [Abstract][Full Text] [Related]
4. DNA methylation regulates B cell activation via repressing Pax5 expression in teleost.
Shi Y; Zhu Z; Chen Q; Chen X
Front Immunol; 2024; 15():1363426. PubMed ID: 38404580
[TBL] [Abstract][Full Text] [Related]
5. DNA Hypomethylation in the TNF-Alpha Gene Predicts Rheumatoid Arthritis Classification in Patients with Early Inflammatory Symptoms.
Pitaksalee R; Parmar R; Hodgett R; Emery P; Ponchel F
Cells; 2023 Sep; 12(19):. PubMed ID: 37830590
[TBL] [Abstract][Full Text] [Related]
6. Cancer Methylation Biomarker Detection in an Automated, Portable, Multichannel Magnetofluidic Platform.
Hasnain AC; Stark A; Trick AY; Ma K; Hsieh K; Cheng Y; Meltzer SJ; Wang TH
ACS Nano; 2024 May; 18(19):12105-12116. PubMed ID: 38669469
[TBL] [Abstract][Full Text] [Related]
7. Paired Box 5 (PAX5) Gene Has Diagnostic and Prognostic Potential in Nasopharyngeal Carcinoma.
Ye J; Huang X; Qin W; Liang P; Zhao J; Ye Y; Ji H; Peng X; Liang Y; Cai Y
Int J Gen Med; 2024; 17():487-501. PubMed ID: 38348125
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of Melanoma Progression and Treatment Resistance: Role of Cancer Stem-like Cells.
Al Hmada Y; Brodell RT; Kharouf N; Flanagan TW; Alamodi AA; Hassan SY; Shalaby H; Hassan SL; Haikel Y; Megahed M; Santourlidis S; Hassan M
Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38275910
[TBL] [Abstract][Full Text] [Related]
9. Role of Epigenetics for the Efficacy of Cisplatin.
Lumpp T; Stößer S; Fischer F; Hartwig A; Köberle B
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256203
[TBL] [Abstract][Full Text] [Related]
10. MFI2 upregulation promotes malignant progression through EGF/FAK signaling in oral cavity squamous cell carcinoma.
Yen WC; Chang KP; Chen CY; Huang Y; Chen TW; Cheng HW; Yi JS; Cheng CC; Wu CC; Wang CI
Cancer Cell Int; 2023 Jun; 23(1):112. PubMed ID: 37309001
[TBL] [Abstract][Full Text] [Related]
11. The Pleiotropy of
Nasri Nasrabadi P; Martin D; Gharib E; Robichaud GA
Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077495
[TBL] [Abstract][Full Text] [Related]
12. DNA Methylation Biomarkers for Prediction of Response to Platinum-Based Chemotherapy: Where Do We Stand?
Tavares NT; Gumauskaitė S; Lobo J; Jerónimo C; Henrique R
Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740584
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic activation of the elongator complex sensitizes gallbladder cancer to gemcitabine therapy.
Xu S; Jiang C; Lin R; Wang X; Hu X; Chen W; Chen X; Chen T
J Exp Clin Cancer Res; 2021 Nov; 40(1):373. PubMed ID: 34823564
[TBL] [Abstract][Full Text] [Related]
14. A DNA methylation-based test for esophageal cancer detection.
Salta S; Macedo-Silva C; Miranda-Gonçalves V; Lopes N; Gigliano D; Guimarães R; Farinha M; Sousa O; Henrique R; Jerónimo C
Biomark Res; 2020 Nov; 8(1):68. PubMed ID: 33292587
[TBL] [Abstract][Full Text] [Related]
15. Aberrant DNA Methylation in Esophageal Squamous Cell Carcinoma: Biological and Clinical Implications.
Lin L; Cheng X; Yin D
Front Oncol; 2020; 10():549850. PubMed ID: 33194605
[TBL] [Abstract][Full Text] [Related]
16. Downstream Effectors of ILK in Cisplatin-Resistant Ovarian Cancer.
Reyes-González JM; Quiñones-Díaz BI; Santana Y; Báez-Vega PM; Soto D; Valiyeva F; Marcos-Martínez MJ; Fernández-de Thomas RJ; Vivas-Mejía PE
Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32260415
[TBL] [Abstract][Full Text] [Related]
17. Targeting Viral DNA and Promoter Hypermethylation in Salivary Rinses for Recurrent HPV-Positive Oropharyngeal Cancer.
Shen S; Saito Y; Ren S; Liu C; Guo T; Qualliotine J; Khan Z; Sadat S; Califano JA
Otolaryngol Head Neck Surg; 2020 Apr; 162(4):512-519. PubMed ID: 32041482
[TBL] [Abstract][Full Text] [Related]
18. Genetic Profiling of Advanced Melanoma: Candidate Mutations for Predicting Sensitivity and Resistance to Targeted Therapy.
Olbryt M; Pigłowski W; Rajczykowski M; Pfeifer A; Student S; Fiszer-Kierzkowska A
Target Oncol; 2020 Feb; 15(1):101-113. PubMed ID: 31980996
[TBL] [Abstract][Full Text] [Related]
19. Propofol improves the function of natural killer cells from the peripheral blood of patients with esophageal squamous cell carcinoma.
Zhou M; Dai J; Zhou Y; Wu J; Xu T; Zhou D; Wang X
Exp Ther Med; 2018 Jul; 16(1):83-92. PubMed ID: 29977357
[TBL] [Abstract][Full Text] [Related]
20. An epigenetic classifier for early stage lung cancer.
Su Y; Fang HB; Jiang F
Clin Epigenetics; 2018; 10():68. PubMed ID: 29796119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
